<?xml version="1.0" encoding="UTF-8"?>
<svg height="750.226" width="550.79738" xmlns="http://www.w3.org/2000/svg">
 <g style="fill:none;">
  <text x="56.693,61.995,66.101,70.589,74.97,79.419,84.515,88.768,93.149,98.559,102.997,106.672,110.877,116.08,121.019,124.694,127.713,132.093,137.297,141.717,144.872,149.96800000000002,154.418,159.513,163.894,168.363,172.038,176.242,178.79,183.043,186.199,190.413,195.61700000000002,200.163,206.994,209.346,212.502,217.804,222.272,225.428,230.553,234.934,239.51,244.714,248.183,253.279,257.816,263.226,268.194,271.967,274.378,278.151,282.659,287.647" y="104.49199999999996" svg_rhmargin="290.499" style="fill:#131413;font-family:ILNNCB+RhxlktAdvTT86d47313;font-size:9.8px;font-style:NORMAL;font-weight:normal;">have been reported to be related with the prognosis of</text>
  <text x="56.693,63.327,69.168,75.80300000000001,78.801,84.005,88.209,91.365,93.766,98.146,103.399,106.555,110.328,113.317,115.865,121.137,125.518,127.879,133.181,138.257,140.698,146.107,150.801,153.741,160.268,166.442,173.38,178.378,180.51399999999998,183.504,190.138,194.391,198.772,201.192,203.633,209.042,212.472,217.676,221.88,227.084,231.288,236.698,241.774,246.154,251.407,254.56300000000002,257.532,262.432,264.784,270.194,274.574,278.22,282.601,285.589" y="116.457" svg_rhmargin="290.489" style="fill:#131413;font-family:ILNNCB+RhxlktAdvTT86d47313;font-size:9.8px;font-style:NORMAL;font-weight:normal;">CRC patients including KRAS, Cyclin-dependent kinase 2</text>
  <text x="56.693,59.701,63.955,69.158,73.421,78.321,81.3,83.43599999999999,86.739,91.12,96.373,101.577,104.928,111.445,115.825,118.873,124.175,128.399,133.603,137.238,139.678,145.088,148.41,155.554,158.896,161.973,166.795,168.93099999999998,172.234,177.134,181.867,184.003,187.365,192.265,196.998,200.154,202.29,205.504,208.768,214.011,217.166,221.439,225.114,229.318,233.091,236.06,238.608,243.881,248.575,250.966,255.347,258.679,263.059,268.312,273.3,278.602,283.169,288.47" y="128.47199999999998" svg_rhmargin="290.606" style="fill:#131413;font-family:ILNNCB+RhxlktAdvTT86d47313;font-size:9.8px;font-style:NORMAL;font-weight:normal;">(cdc2), and Cathepsin D [5, 35, 36]. Interestingly enough,</text>
  <text x="56.683,64.133,68.516,72.163,77.465,81.916,85.593,89.819,95.024,99.965,103.642,106.643,111.026,116.22999999999999,120.651,123.809,128.955,133.338,136.494,140.915,146.121,150.347,153.504,155.897,160.28,165.535,168.692,172.465,176.936,183.768,186.161,189.319,194.62099999999998,198.974,205.502,211.727,218.668,223.666,228.117,236.282,241.429,244.586,248.812,254.224,257.38,261.801,264.958,270.105,278.271,283.212,286.889" y="140.48699999999997" svg_rhmargin="290.662" style="fill:#131413;font-family:ILNNCB+RhxlktAdvTT86d47313;font-size:9.8px;font-style:NORMAL;font-weight:normal;">Nash reported that patients with KRAS mutant tumors</text>
  <text x="56.683,59.839,65.013,69.394,72.55000000000001,75.44,79.821,84.456,89.66,93.188,97.568,101.184,104.957,109.181,114.38499999999999,117.344,122.646,125.057,129.751,135.053,137.924,140.472,144.853,149.204,153.585,156.005,159.778,162.747,167.736,170.588,173.576,180.103,182.475,186.042,190.805,195.705,198.684,203.985,208.209,213.413,216.372,220.145,222.556,227.25,232.474,235.022,237.746,240.186,244.567,248.8,254.21,257.189,259.737,264.11800000000005,267.058,273.888,278.847,282.522,286.099" y="152.452" svg_rhmargin="290.48" style="fill:#131413;font-family:ILNNCB+RhxlktAdvTT86d47313;font-size:9.8px;font-style:NORMAL;font-weight:normal;">that expressed high levels of Ki-67 had significantly worse</text>
  <text x="56.683,63.827,68.757,73.75500000000001,79.928,83.084,88.258,92.639,98.04899999999999,104.134,109.338,113.542,116.698,119.099,123.479,128.732,131.888,135.661,141.825,148.655,151.066,154.222,159.524,165.58,172.106,178.339,185.277,190.27499999999998,196.42,203.25,205.661,208.209,213.256,216.715,219.871,224.144,229.348,233.729,239.794,242.95,248.124,256.17,261.266,264.784,268.557,274.76,277.916,283.041,287.422" y="164.46699999999998" svg_rhmargin="290.578" style="fill:#131413;font-family:ILNNCB+RhxlktAdvTT86d47313;font-size:9.8px;font-style:NORMAL;font-weight:normal;">DFS than patients with KRAS wild-type tumors that</text>
  <text x="56.683,61.064,65.699,70.903,74.431,78.811,82.427,86.2,90.424,95.628,100.685,103.125,108.221,115.052,120.02,122.568,126.948,131.437,135.612,138.16,143.206,148.302,151.154,156.133,162.659,165.031,168.598,173.361,178.261,180.397,185.375,187.816,193.225,198.243,200.791,205.044,209.424,212.413,214.961,220.234,224.928,229.926,233.081,238.256,242.636,245.792,250.731,255.112,260.08,268.243,273.173,275.721,280.993,285.374" y="176.48199999999997" svg_rhmargin="290.578" style="fill:#131413;font-family:ILNNCB+RhxlktAdvTT86d47313;font-size:9.8px;font-style:NORMAL;font-weight:normal;">expressed low level of Ki-67, indicating that combined</text>
  <text x="56.683,61.064,66.091,71.295,73.686,76.234,80.487,84.868,87.857,90.405,95.344,100.75399999999999,104.301,109.397,112.24900000000001,115.757,118.912,124.038,128.418,132.035,136.416,139.972,145.176,148.704,153.085,158.112,160.66,164.913,168.069,170.47,174.831,179.212,182.769,187.463,191.726,197.135,201.359,205.132,208.67,216.715,219.263,223.801,229.103,232.25900000000001,235.766,240.97,244.498,249.486,253.975,256.346,261.55,265.93100000000004,269.439,277.485,282.581,286.099" y="188.447" svg_rhmargin="290.48" style="fill:#131413;font-family:ILNNCB+RhxlktAdvTT86d47313;font-size:9.8px;font-style:NORMAL;font-weight:normal;">application of these predictive genes might provide more</text>
  <text x="56.683,61.171,65.415,67.855,73.157,77.38,82.476,84.917,89.298,93.08,98.284,101.812,106.8,111.494,116.776,121.764,125.537,128.565,131.006,135.387,139.228,141.668,147.077,149.772,154.868,158.386,166.55,170.803,173.959,176.359,181.348,186.758,190.589,194.969,200.222,205.42600000000002,209.238,212.09,217.235,220.91,223.928,229.23,233.454,237.12900000000002,240.941,243.381,251.544,256.748,260.217,265.205,269.694,274.07500000000005,277.847,281.003,286.128" y="200.462" svg_rhmargin="290.509" style="fill:#131413;font-family:ILNNCB+RhxlktAdvTT86d47313;font-size:9.8px;font-style:NORMAL;font-weight:normal;">valuable prognostic information and further improve the</text>
  <text x="56.683,61.064,63.425,65.973,71.246,73.686,78.066,82.3,84.848,87.455,92.659,96.128,100.508,105.594,108.035,112.415,115.463,117.903,122.999,128.409,130.888,135.984,138.836,141.315,146.519,150.047,155.143,159.68,165.09,170.058,173.831,176.183,179.956,182.533,185.385,190.354,194.02900000000002,196.586,203.103,209.121,215.756,218.293,223.497,227.701,230.857,233.258,237.638,242.891,246.047,249.82" y="212.47699999999998" svg_rhmargin="251.956" style="fill:#131413;font-family:ILNNCB+RhxlktAdvTT86d47313;font-size:9.8px;font-style:NORMAL;font-weight:normal;">clinical prediction of prognosis for CRC patients.</text>
  <text x="64.68,67.943,73.353,76.753,81.134,86.23,91.718,96.098,98.646,103.948,107.721,110.269,115.365,120.774,122.91,126.409,129.565,134.867,139.248,142.677,147.881,151.556,155.936,159.709,164.09,169.5,172.656,176.124,184.288,188.668,191.824,196.205,199.713,204.093,209.503,213.883,216.431,220.812,224.585,227.133,230.906,234.404,239.608,243.989,252.152,257.248,262.657,266.43,269.586,273.261,277.641,280.797,285.315" y="224.442" svg_rhmargin="290.519" style="fill:#131413;font-family:ILNNCB+RhxlktAdvTT86d47313;font-size:9.8px;font-style:NORMAL;font-weight:normal;">In conclusion, the present meta analysis demonstrated</text>
  <text x="56.683,59.839,65.14,69.521,72.677,78.4,83.701,86.249,90.944,96.24600000000001,101.929,108.456,111.004,114.571,119.471,124.37100000000001,130.045,134.426,139.218,144.422,148.097,152.477,156.348,160.121,162.669,167.765,173.17499999999998,178.858,182.631,185.179,189.874,195.283,197.831,200.683,203.231,207.611,211.992,217.519,220.675,223.223,227.604,233.277,238.481,242.156,246.537,251.74,254.288,258.669,261.962,265.735,271.428,276.632,281.728,286.824" y="236.457" svg_rhmargin="290.499" style="fill:#131413;font-family:ILNNCB+RhxlktAdvTT86d47313;font-size:9.8px;font-style:NORMAL;font-weight:normal;">that high Ki-67 expression significantly predicts poor</text>
  <text x="56.683,61.779,66.267,70.648,74.323,78.792,81.34,83.888,89.562,93.335,98.636,102.654,107.143,109.691,114.179,118.56,121.108,126.801,131.182,136.591,141.79500000000002,147.489,152.693,155.241,159.014,163.394,167.951,171.724,176.105,181.779,184.631,188.306,192.686,197.067,202.809,206.582,211.884,215.853,220.341,222.889,227.378,231.837,234.385,236.521,242.215,249.761,252.309,257.003,262.305,268.008,274.535,277.083,280.65,285.55" y="248.47199999999998" svg_rhmargin="290.45" style="fill:#131413;font-family:ILNNCB+RhxlktAdvTT86d47313;font-size:9.8px;font-style:NORMAL;font-weight:normal;">overall survival and disease free survival. High Ki-67</text>
  <text x="56.683,61.064,65.856,71.06,74.735,79.115,82.986,86.759,89.307,94.403,99.813,103.34,111.504,115.884,120.265,123.861,127.634,132.015,136.052,140.541,144.922,148.469,152.948,156.721,160.317,164.698,168.137,172.626,177.006,179.554,184.856,189.237,194.332,196.88,201.261,204.877,210.081,213.756,218.136,223.419,225.967,230.347,233.503,236.051,240.539,244.92,248.477,253.573,256.121,261.217,269.38,273.878,277.553,282.453,286.834" y="260.437" svg_rhmargin="290.509" style="fill:#131413;font-family:ILNNCB+RhxlktAdvTT86d47313;font-size:9.8px;font-style:NORMAL;font-weight:normal;">expression may serve as a valuable predictive biomarker</text>
  <text x="56.683,59.535,64.631,68.306,71.256,76.459,81.634,86.73,90.405,93.364,98.568,102.243,107.339,112.033,117.442,122.617,126.39,128.938,132.71099999999998,135.661,138.208,143.618,146.597,153.232,159.249,165.884,168.823,174.027,178.408,181.563,184.111,188.492,193.999,197.282,201.055" y="272.452" svg_rhmargin="203.191" style="fill:#131413;font-family:ILNNCB+RhxlktAdvTT86d47313;font-size:9.8px;font-style:NORMAL;font-weight:normal;">for poor prognosis in CRC patients.</text>
  <text x="56.693,61.455,65.828,70.2,72.855,76.68,80.43,82.305,86.055,88.627,90.502,94.717,98.932" y="291.691" svg_rhmargin="102.052" style="fill:#131413;font-family:ILNNBA+VyfpxgAdvTT99c4c969;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Abbreviations</text>
  <text x="56.693,60.908,62.153,64.403,68.618,72.6,76.193,82.283,86.265,88.53,92.512,96.105,98.287,101.64,105.787,109.065,110.31,112.59,116.805,121.02,122.265,124.492,128.707,132.689,134.249,138.232,142.215,144.502,147.779,151.132,155.114,158.392,161.984,164.166,165.411,167.691,171.906,173.534,174.779,176.991,181.206,185.189,189.171,191.121,192.749,196.806,200.399,204.381,207.658,211.25099999999998,213.501,215.061,219.043,221.308,224.901,227.083,230.436,233.788,235.348,236.59300000000002,238.895,243.11,246.86,251.075,252.32,254.6,258.815,262.798,264.358,268.34,270.523,274.115,277.392,279.657,283.01" y="300.646" svg_rhmargin="284.57" style="fill:#000000;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">C: Chemotherapy; CC: Colon cancer; CI: Confidence interval; CRC: Colorectal</text>
  <text x="56.693,59.97,63.323,67.305,70.583,74.175,76.358,77.60300000000001,79.883,84.098,87.847,92.13,95.482,101.257,102.50200000000001,104.775,108.99,112.972,114.532,118.515,120.697,124.289,127.567,129.832,133.184,134.744,137.032,138.592,140.152,143.504,147.097,149.28,151.544,157.634,161.227,163.492,166.844,169.574,171.839,175.191,177.921,181.514,184.244,185.489,187.829,192.666,196.101,199.536,200.781,203.076,207.913,209.473,212.203,215.796,219.148,221.878,225.47099999999998,227.736,229.686,231.868,235.461,239.054,241.34,244.07,247.97,250.153,253.505,255.065,258.418,261.77,263.33" y="309.661" svg_rhmargin="264.575" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">cancer; CRCLM: Colorectal liver metastases; DFS: Disease free survival;</text>
  <text x="56.693,61.38,65.13,66.375,68.655,73.343,76.695,79.658,83.01,85.193,89.251,91.56,93.742,97.095,99.36,100.92,104.902,106.147,108.397,109.957,114.645,118.86,120.105,122.4,123.96,130.049,136.139,140.039,144.022,148.004,151.987,153.547,156.277,158.542,162.524,165.801,169.784,173.376,179.466,181.131,183.861,186.126,188.309,191.586,192.83100000000002,195.074,199.836,204.831,208.266,209.511,211.798,216.561,220.153,225.538,228.816,232.168,234.898,237.163,238.723,242.315,244.498,249.493,251.758,254.023,257.495,262.88,266.23199999999997,268.49,273.485,277.385,280.737,282.297,283.857,286.122" y="318.676" svg_rhmargin="289.399" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">HR: Hazard ratio; IHC: Immunohistochemistry; NOS: Newcastle-Ottawa Quality</text>
  <text x="56.693,61.065,63.795,66.525,70.118,72.848,75.578,81.668,85.26,89.242,91.507,93.825,97.26,100.537,103.89,105.45,109.042,110.287,112.59,117.352,121.102,122.34700000000001,124.604,129.367,133.349,135.61399999999998,137.872,140.054,143.647,147.704,151.687,153.869,156.134,159.727,163.784,165.029,167.354,172.349,176.099,177.344,179.601,184.596,188.654,192.711,195.441,197.684,199.866,203.218,205.483,207.043,211.026,212.27100000000002,214.581,219.576,223.011,224.256,226.543,231.538,234.891,238.483,240.665,244.018,245.578,247.138,249.448,252.178,256.078,258.26,261.613,263.173,266.525,269.878,271.438" y="327.691" svg_rhmargin="272.683" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Assessment Scale; NR: Not reported; OR: Odds ratio; OS: Overall survival;</text>
  <text x="56.693,60.443,61.687999999999995,63.953,67.703,71.055,75.113,76.673,80.655,82.92,86.902,90.495,92.677,96.03,100.087,103.47,104.715,106.927,110.677,114.892,116.137,118.432,122.182,125.774,129.052,131.317,134.669,136.229,138.502,141.779,145.132,149.114,152.392,155.984,158.167,159.412,161.691,165.126,166.371,168.666,172.101,176.001,178.184,182.241,185.834,188.016" y="336.646" svg_rhmargin="191.293" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">R: Radiotherapy; RC: Rectal cancer; S: Surgery</text>
  <text x="56.693,61.455,64.808,68.558,72.773,76.988,82.53,84.405,88.23,92.52,96.81,103.237,107.062,111.277,113.85" y="355.868" svg_rhmargin="116.97" style="fill:#131413;font-family:ILNNBA+VyfpxgAdvTT99c4c969;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Acknowledgments</text>
  <text x="56.693,60.283,64.421,66.181,68.911,72.021,74.906,77.327,81.382,85.595,88.873,91.997,97.552,101.06,103.79,106.953,109.058,113.113,117.251,121.464,125.211,129.269,132.469,136.682,139.95999999999998,143.084,147.844,151.9,155.407,159.545,163.758,168.008,172.146,176.283,180.34099999999998,183.481,187.386,189.724,193.862,197.369,199.085,203.222,206.655,208.37,211.878,213.438,216.586,221.428,225.176,228.684,230.399,232.782,236.76500000000001,239.927,244.972,248.712,252.925,256.432,258.77,261.19,267.436,271.183,275.321" y="364.883" svg_rhmargin="277.586" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">This study was funded by Guangdong Provincial Health Department</text>
  <text x="56.693,58.797,63.713,67.849,69.09400000000001,72.27,76.751,80.55,84.296,88.042,91.789,95.535,99.281,103.027,105.131,106.376,109.552,113.126,117.262,120.855,124.008,126.112,130.248,132.007,133.706,137.842,143.381,145.094,149.23,153.28799999999998,156.427,161.245,165.149,168.501,171.67,173.384,176.11399999999998,179.283,181.701,185.837,189.42999999999998,192.584,198.137,201.883,205.941,209.08,210.793,212.552,216.688,219.808,222.924,227.061,229.011,232.164,236.923,240.977,244.483,248.619,252.83,257.079,261.215,265.351" y="373.838" svg_rhmargin="269.408" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">(No: A2016450). The following URL is the web link of Guangdong</text>
  <text x="56.693,60.6,62.94,67.08,70.59,72.308,76.448,79.883,81.6,85.11,86.67,89.812,94.657,98.407,101.917,103.635,106.057,110.04,113.145,118.192,121.935,126.149,129.659,131.999,134.422,140.669,144.419,148.559,150.82399999999998,154.004,156.074,160.214,162.636,165.014,169.266,170.624,173.346,176.121,181.619,187.161,192.704,194.106,198.321,202.573,208.071,210.958,213.381,214.783,218.998,223.138,226.648,228.051,231.486,235.626,238.393,240.547" y="382.853" svg_rhmargin="241.792" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Provincial Health Department (http://www.gdwst.gov.cn/).</text>
  <text x="56.693,60.443,64.658,68.873,73.163,75.038,79.253" y="402.075" svg_rhmargin="83.543" style="fill:#131413;font-family:ILNNBA+VyfpxgAdvTT99c4c969;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Funding</text>
  <text x="56.693,60.128,64.11,65.67,68.4,70.695,73.425,75.69,79.59,83.648,86.926,89.175,94.56,97.912,100.64200000000001,102.952,104.902,108.802,112.785,116.842,120.435,124.493,126.764,130.822,134.1,136.342,141.029,144.622,147.974,149.534,151.799,155.782,158.054,162.892,166.484,170.541,173.894,176.076,178.341,184.529,188.121,192.104,194.369,196.604,199.956,203.939,207.99699999999999,210.268,213.703,215.263,219.246,222.598,226.581,229.858,233.451,235.783,240.621,244.213,248.27,251.623,253.805,256.07,262.16,265.753,269.735,272.0,274.28,278.263" y="411.09" svg_rhmargin="280.213" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">This study was funded by Health Department and Finance Department of</text>
  <text x="56.693,61.298,65.198,68.55,72.533,76.59,80.648,84.63,88.612,92.66999999999999,95.017,98.767,100.95,104.932,108.285,109.845,113.827,117.105,120.697,121.94200000000001,124.215,127.649,131.632,135.225,137.482,142.087,144.269,147.622,151.604,153.869,156.187,160.949,164.849,170.939,174.996,178.589,180.772,183.059,188.444,191.796,194.52599999999998,196.776,201.538,205.521,206.766,209.023,213.396,216.988,220.648,224.241,227.833,231.426,235.018,238.611,239.855,243.29,247.273,250.86599999999999,253.13,255.08,258.98,262.963,267.02,268.58,272.563" y="420.045" svg_rhmargin="276.62" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Guangdong Province. The Grant Number was No: A2016450.The funding</text>
  <text x="56.693,60.045,63.323,66.6,70.583,74.483,78.465,80.73,83.055,88.44,91.792,94.522,96.772,100.522,106.297,110.047,112.305,115.897,119.49,123.082,126.674,127.91900000000001,130.222,133.657,137.639,141.232,143.489,145.439,149.339,153.322,157.379,160.972,163.155,165.426,169.409,172.761,176.819,179.091,183.074,187.05700000000002,189.351,191.534,195.516,197.076,200.66899999999998,202.904,204.463,208.446,210.726,214.783,218.376,221.106,222.666,226.723,230.706,231.951,234.253,238.311,241.663,243.928,247.28,249.56,252.838,256.82,258.38,259.94,263.533,266.81,269.075,270.635,274.618,278.6" y="429.06" svg_rhmargin="279.845" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">account was RMB 5000. The funder had no role in design, data collection,</text>
  <text x="56.693,60.75,64.103,66.368,69.72,72.0,75.353,79.335,82.688,84.248,87.525,90.255,91.815,94.545,96.832,100.185,104.167,108.225,110.497,114.555,118.455,122.512,124.072,125.632,128.362,132.345,134.647,138.629,140.57899999999998,142.867,145.132,149.114,152.707,154.942,158.999,161.182,164.774,167.504,171.096,175.079,177.344,179.661,185.751,189.104,193.086,196.986,199.716,202.994,205.176,206.736,210.793,213.058" y="438.075" svg_rhmargin="214.303" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">data analysis and publish of the present manuscript.</text>
  <text x="56.693,61.455,65.205,68.955,70.83,72.705,76.455,80.828,82.703,84.578,86.453,89.025,92.775,95.07,99.285,101.625,103.912,108.202,111.952,114.525,118.275,120.525,124.274,128.489,132.779,135.037,141.359,145.109,147.682,151.507,154.162,156.037,159.787,161.736" y="457.297" svg_rhmargin="164.856" style="fill:#131413;font-family:ILNNBA+VyfpxgAdvTT99c4c969;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Availability of data and materials</text>
  <text x="56.693,60.128,64.11,67.703,69.96,74.018,77.37,79.635,82.988,85.718,89.31,91.575,94.305,96.607,99.337,103.237,107.295,111.352,115.335,117.517,119.782,121.342,125.325,129.383,131.699,133.964,137.947,141.54,143.834,147.112,151.094,155.077,158.354,159.914,163.814,166.544,168.104,172.086,176.069,178.79899999999998,181.079,185.061,187.011,189.299,191.564,195.546,199.13899999999998,201.374,205.431,207.613,211.206,213.936,217.528,221.511,223.77599999999998,226.093,228.823,231.088,234.988,239.046,242.32399999999998,244.573,249.958,253.55,255.733,259.326,261.635,263.195,267.178,270.455,272.015,275.915,279.972,283.565" y="466.252" svg_rhmargin="287.622" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">The datasets supporting the conclusions of the present study were included</text>
  <text x="56.693,58.253,62.236,64.515,66.78,70.763,74.35600000000001,76.59,79.943,82.125,84.39,85.95,89.227,90.787,94.38" y="475.267" svg_rhmargin="95.625" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">in the article.</text>
  <text x="56.693,61.455,65.67,68.243,72.458,76.673,79.328" y="494.489" svg_rhmargin="82.448" style="fill:#131413;font-family:ILNNBA+VyfpxgAdvTT99c4c969;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Authors</text>
  <text svg_rhmargin="84.202" x="82.485,84.203" y="494.489" style="fill:#131413;font-family:IMAKLB+BmdqlwAdvTT99c4c969+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">’ </text>
  <text x="86.453,89.805,94.02,98.235,100.807,103.462,105.337,109.71,113.925,116.497,118.372,122.587,126.802" y="494.489" svg_rhmargin="129.922" style="fill:#131413;font-family:ILNNBA+VyfpxgAdvTT99c4c969;font-size:7.5px;font-style:NORMAL;font-weight:normal;">contributions</text>
  <text x="56.685,60.668,64.65,65.89500000000001,68.138,72.12,77.89500000000001,80.213,83.565,87.547,91.60499999999999,93.877,97.23,101.21300000000001,103.455,107.512,111.105,113.835,115.395,119.452,123.435,127.027,131.085,133.387,135.652,139.634,143.22699999999998,145.462,148.192,150.457,154.357,158.414,161.692,162.937,165.246,169.229,173.211,174.45600000000002,176.699,180.449,183.884,185.129,187.416,192.104,198.194,199.439,201.704,205.056,209.113,210.358,212.646,215.998,219.981,224.039,226.311,229.663,233.64600000000002,235.888,239.946,243.538,245.72,247.67,251.653,253.918,260.008,263.6,267.658,269.908,272.173,276.155" y="503.444" svg_rhmargin="279.747" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">ZZ, ZM and LZ designed the study. ZZ, YF, HW, LX, and LZ performed the</text>
  <text x="56.685,58.868,62.46,65.19,68.783,72.135,74.318,77.595,81.578,82.82300000000001,85.148,89.13,93.113,95.355,98.707,102.69,106.74799999999999,109.02,113.002,118.777,121.035,124.312,128.294,129.854,131.414,135.007,138.284,140.549,144.224,148.28199999999998,150.517,153.869,157.852,161.91,164.181,167.534,171.516,174.869,176.429,179.706,182.669,186.261,190.319,192.644,194.909,198.891,202.48399999999998,204.718,208.776,212.128,214.393,217.746,218.991,221.271,225.253,229.236,231.531,234.883,238.866,242.924,245.195,249.178,254.953,257.21,262.595,264.778,268.76,271.025,274.618,276.883,279.147,283.13" y="512.4590000000001" svg_rhmargin="286.722" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">research; ZZ and ZM collected and analyzed the data; ZZ and ZM wrote the</text>
  <text x="56.685,60.743,64.095,68.153,71.745,73.928,75.173,77.49,80.843,84.82600000000001,87.067,90.42,96.51,100.102,104.085,108.142,111.735,115.793,118.08,120.345,124.327,127.92,130.214,133.567,135.749,138.014,139.574,142.852,144.412,148.004,149.249,151.529,155.512,159.495,161.737,165.089,168.366,170.631,172.904,176.256,178.986,181.236,183.501,187.484,191.077,193.371,196.101,200.001,204.058,210.148,211.708,214.438,217.168,218.728,222.711" y="521.473" svg_rhmargin="226.693" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">paper; LZ amended the article. ZZ act as the submission</text>
  <text x="226.761" y="521.473" svg_rhmargin="228.006" style="fill:#131413;font-family:ILNNAP+PmmnvnAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">’</text>
  <text x="228.006,230.736,232.993,237.051,240.95,244.303,246.485,249.838,253.82,256.085,260.068,262.251,264.568,267.92,271.903" y="521.473" svg_rhmargin="275.96" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">s guarantor and</text>
  <text x="56.685,58.95,62.303,65.423,69.015,71.745,74.033,76.215,79.808,82.538,86.595,90.577,94.56,97.29,98.85,102.907,104.467,106.027,107.587,109.852,113.13000000000001,115.477,117.427,121.41,123.59299999999999,125.85,128.114,132.097,135.69,137.924,139.484,143.467,145.732,149.324,153.382,155.564,157.199,159.464,162.742,164.969,168.951,170.90099999999998,173.189,175.454,179.436,183.029,185.264,190.649,194.631,196.814,199.934,202.214,205.566,208.296,210.546,213.898,216.156,221.541,225.523,229.506,231.066,234.658,235.903,238.206,240.156,242.338,246.32,252.41,254.705,256.265,260.248,263.525,267.118,271.175,273.44,275.0,278.982" y="530.488" svg_rhmargin="282.964" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">takes responsibility for the integrity of the work as a whole, from inception</text>
  <text x="56.685,58.95,62.933,65.19,69.248,73.148,77.205,78.765,80.325,83.055,87.038,90.63,94.68799999999999,96.997,100.35,102.532,104.797,106.357,109.635,111.195,114.787,116.03200000000001,118.312,122.685,124.245,125.805,128.062,131.414,135.314,137.579,141.562,145.544,147.727,150.457,152.782,154.964,158.557,161.909,163.469,167.061,172.446,176.039,180.09699999999998,182.376,184.641,188.624,192.21699999999998,194.511,200.601,203.954,207.936,211.836,214.566,217.843,220.026,221.586,225.643,227.908,229.153,231.471,235.843,237.403,238.963,241.221,244.573,248.473,250.738,254.72,258.703,260.885,263.615,265.94,268.123,271.715,275.068" y="539.443" svg_rhmargin="279.125" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">to published article. All authors reviewed the manuscript. All authors read</text>
  <text x="56.685,60.038,64.02,68.078,70.35,73.703,77.76,81.818,84.0,87.982,91.335,94.927,98.98500000000001,101.302,103.567,107.55,111.143,113.377,115.327,116.887,120.87,124.222,125.782,128.062,134.152,137.504,141.487,145.469,148.199,151.477,153.659,155.219,159.277,161.542" y="548.458" svg_rhmargin="162.787" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">and approved the final manuscript.</text>
  <text x="56.685,60.51,63.083,67.298,69.173,72.525,75.64500000000001,77.948,81.698,86.07,90.442,93.097,97.312,101.062,104.812,106.687,108.96,112.71,116.925,121.215,123.472,126.824,131.039,135.254,138.374,142.199,146.414,148.986,151.304,153.877,158.092,160.372,164.744,168.494,171.149,173.721,175.596,178.949,180.824,185.196,188.946,191.519" y="567.6800000000001" svg_rhmargin="195.344" style="fill:#131413;font-family:ILNNBA+VyfpxgAdvTT99c4c969;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Ethics approval and consent to participate</text>
  <text x="56.685,61.448,65.43,67.69500000000001,69.953,73.305,77.363,81.42,82.98,84.54,87.818,91.17,95.227,96.787,100.38" y="576.6949999999999" svg_rhmargin="101.625" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Not applicable.</text>
  <text x="56.685,61.058,65.273,69.488,72.608,76.433,80.648,83.22,85.545,87.885,92.1,94.755,96.997,101.37,105.585,109.957,111.832,113.707,117.06,120.81,123.382,125.257,129.472" y="595.857" svg_rhmargin="133.687" style="fill:#131413;font-family:ILNNBA+VyfpxgAdvTT99c4c969;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Consent for publication</text>
  <text x="56.685,61.058,62.618,64.178,66.435,68.7,72.683,76.27600000000001,78.57,81.923,85.823,88.087,92.07,96.052,98.235,100.965,103.23,107.212,110.565,113.917,117.51,119.782,123.135,127.192,129.374,132.967,136.559,140.617,142.912,145.177,149.16,151.417,155.474,159.374,163.432,164.991,166.551,169.281,173.264,175.566,178.919,181.101,183.366,184.926,188.204,189.764,193.357,195.636,197.196,201.179,203.458,205.723,209.706,213.29899999999998,215.533,218.811,222.711,224.893,227.158,230.751,234.733,236.998,239.233,245.323,248.675,252.733,256.085,259.048,260.608,264.59,268.183" y="604.8720000000001" svg_rhmargin="269.428" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">All the authors have agreed to publish article in the current magazine.</text>
  <text x="56.685,61.058,65.273,71.595,75.968,79.793,82.365,84.24,88.455,92.745,95.062,96.937,101.152,103.725,107.55,110.205,114.03,117.15,119.722" y="624.095" svg_rhmargin="122.842" style="fill:#131413;font-family:ILNNBA+VyfpxgAdvTT99c4c969;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Competing interests</text>
  <text x="56.685,60.12,64.103,67.696,69.953,73.305,77.205,79.47,83.453,87.435,89.617,92.34700000000001,94.672,98.73,102.322,105.6,107.16,110.512,112.695,116.288,118.537,120.802,124.785,128.137,130.402,132.712,134.977,138.959,142.552,145.82999999999998,148.072,152.054,155.407,158.759,162.35199999999998,164.624,168.606,172.589,174.884,178.161,182.144,188.234,192.291,195.884,198.149,199.709,203.691,207.749,210.036,211.596,215.578,217.843,221.436,223.618,227.211,229.941,232.206,234.936" y="633.049" svg_rhmargin="236.181" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">The authors declare that they have no competing interests.</text>
  <text x="56.693,62.585,68.476,74.584,77.365,80.146,84.544,90.549,95.905" y="658.268" svg_rhmargin="99.768" style="fill:#131413;font-family:ILNMLO+QmndbrAdvTTaf7f9f4f.B;font-size:10.3px;font-style:NORMAL;font-weight:normal;">Publisher</text>
  <text x="99.891" y="658.268" svg_rhmargin="102.466" style="fill:#131413;font-family:IMAKLC+FwxlbrAdvTTaf7f9f4f.B+20;font-size:10.3px;font-style:NORMAL;font-weight:normal;">’</text>
  <text x="102.446,106.844,109.929,117.001,122.961,126.706" y="658.268" svg_rhmargin="132.062" style="fill:#131413;font-family:ILNMLO+QmndbrAdvTTaf7f9f4f.B;font-size:10.3px;font-style:NORMAL;font-weight:normal;">s Note</text>
  <text x="56.693,60.128,64.005,66.188,67.575,71.558,75.458,79.05,81.233,83.108,87.757,91.11,93.202,97.102,99.157,102.75,104.655,106.837,110.265,116.355,119.565,121.125,124.949,127.679,129.599,133.582,137.024,140.924,143.032,145.214,148.364,149.924,151.882,157.267,158.684,160.949,164.93200000000002,166.731,168.914,172.341,176.399,179.601,181.784,185.84199999999998,187.709,189.974,193.957,195.816,197.376,201.089,203.271,204.658,207.388,211.288,212.848,215.991,218.256,219.621,223.603,227.391,230.743,232.303,234.193,237.471,238.843,242.195,243.605,249.695,252.42499999999998,254.263,255.823,259.806,261.688,265.745,269.458,273.515,274.902,276.462,279.042,283.025,286.467" y="667.282" svg_rhmargin="290.524" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Springer Nature remains neutral with regard to jurisdictional claims in published</text>
  <text x="56.693,62.783,65.993,70.05,72.78,74.61,77.963,81.81,85.868,87.817,89.377,93.15,95.88,97.965,99.525,101.647,105.547,107.655,109.215,112.987,116.97,120.187,121.747,123.705,126.937,128.887,130.679,132.239,133.627,135.187,138.389,140.654,142.019,146.002,149.842,152.452" y="676.237" svg_rhmargin="153.697" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">maps and institutional affiliations.</text>
  <text x="56.693,60.675,64.425,67.778,71.528,73.245,76.838,80.588,84.803,86.28,88.552,92.377,96.202,98.475,104.49,108.082,110.497,113.85,117.99,120.3,124.125,127.949,131.774,135.599,137.872,142.402,145.754,149.107,152.857,157.072,159.487,163.236,167.451,168.928,171.261,175.086,178.911,181.124,183.854,187.446,191.586,195.644,199.236,201.651,205.161,207.486,211.311,215.136,218.961" y="694.267" svg_rhmargin="222.786" style="fill:#131413;font-family:ILNNAN+RwhcrnAdvTTe45e47d2;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Received: 22 March 2018 Accepted: 28 January 2019</text>
  <path d="M56.693 695.969 L188.673 695.969 L188.673 706.739 L56.693 706.739 " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <rect style="stroke:blue;stroke-width:0.3;" x="56.693" y="695.969" height="10.8" width="131.999" title="12"/>
  <text x="56.693" y="695.969" class="image" id="image.12.1" width="131" height="10">image.12.1.57_189.696_707</text>
  <text x="56.693,60.908,64.733,67.073,70.898,73.553,77.378,81.593,84.945,88.77" y="722.444" svg_rhmargin="91.89" style="fill:#131413;font-family:ILNNBA+VyfpxgAdvTT99c4c969;font-size:7.5px;font-style:NORMAL;font-weight:normal;">References</text>
  <text x="56.693,60.103,61.286,71.714,75.067,78.569,80.732,82.304,85.486,88.60000000000001,91.596,94.13,95.313,98.267,101.62,105.493,108.995,111.158,112.73,116.603,122.479,125.753,127.995,131.269,133.482,136.664,142.44899999999998,145.439,147.025,148.208,151.162,155.869,157.348,160.459,163.177,167.029,168.601,170.753,173.699,177.352,178.535,181.488,184.841,187.525,191.027,193.1,196.076,199.429,200.612,203.566,209.142,212.416,214.658,218.566,222.069,224.232,226.825,229.73,233.866,235.049,238.003,241.634,245.137,248.988,252.562,254.148,257.931,260.836,266.447,267.63,270.584,274.215,277.489,279.652,282.706,284.278" y="731.458" svg_rhmargin="288.061" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin</text>
  <text svg_rhmargin="271.921" x="71.719,76.312,81.981,83.164,86.117,89.463,93.315,95.471,101.367,104.656,108.43900000000001,111.344,116.05,117.233,120.187,123.818,126.031,129.213,132.327,135.323,138.669,139.852,142.806,146.886,150.174,154.083,157.258,160.775,162.848,165.767,167.353,171.261,174.436,176.022,179.988,183.398,187.356,190.531,193.94400000000002,196.884,200.173,204.024,207.879,210.833,216.729,220.581,222.794,225.007,228.296,229.882,231.361,233.674,236.788,239.741,244.954,248.806,250.962,252.548,256.513,261.726,263.205,267.221,270.738,271.921" y="104.48900000000003" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">DM, Forman D, Bray F. Cancer incidence and mortality worldwide: </text>
  <text x="319.751,322.416,326.271,330.068,332.277,335.455,338.967,341.632,342.815,345.772,351.664,355.176,357.385,361.24,365.151,369.006,371.599,374.62,377.905,381.76,385.615,388.564,394.456,397.741,399.223,403.184,405.257,408.172,412.14,415.425,417.634,419.899,423.412,425.564,429.418,432.011,434.976,436.564,440.34700000000004,443.255,447.736,451.021,455.837,459.521,464.337,468.42,472.673,477.197,480.155,483.667,487.08,490.643,494.155,495.33799999999997,498.295,499.777,503.738,505.89,508.84,511.284,514.226,518.309,521.593,525.448,528.682,532.095,534.354" y="104.48900000000003" svg_rhmargin="535.537" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer.</text>
  <text x="319.751,323.166,326.724,330.238,333.753,335.002,338.517,342.032,345.546,346.795,350.31,353.825" y="113.44399999999996" svg_rhmargin="357.238" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">2015;136:359</text>
  <text x="357.285" y="113.44399999999996" svg_rhmargin="360.847" style="fill:#131413;font-family:ILNNAP+PmmnvnAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="360.969,364.484,367.899" y="113.44399999999996" svg_rhmargin="369.082" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">86.</text>
  <text x="304.732,308.148,309.331,319.757,324.363,328.277,332.06,335.134,337.745,343.754,344.937,347.946,351.347,354.92,358.333,361.385,364.053,368.658,369.841,372.907,376.594,378.235,384.02000000000004,387.08,391.728,395.472,396.655,399.721,403.18,406.41,410.417,412.686,416.315,419.09,421.864,423.506,427.477,431.26,434.334,438.305,440.157,443.182,447.26,450.832,454.462,455.645,458.654,462.732,466.305,469.934,471.117,474.127,477.528,481.499,485.35400000000004,488.413,492.1,493.734,496.003,499.632,503.045,506.04,507.739" y="122.74400000000003" svg_rhmargin="511.522" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">2. Huh JW, Lee JH, Kim HR. Expression of p16, p53, and Ki-67 in</text>
  <text x="319.758,323.047,327.006,328.706,332.672,334.92,338.508,341.797,344.181,347.541,349.023,352.077,355.48,359.503,363.133,367.092,371.051,374.339,377.742,380.012,383.301,385.001,388.96,392.918,398.879,402.282,403.465,406.476,409.661,412.714,415.49,417.874,421.783,425.813,428.92699999999996,432.011,435.964,437.816,440.836,444.419,448.044,451.457,454.505,457.282,461.192,463.456,467.48,469.182,472.465,475.869,477.521,479.222,482.33599999999996,485.348,487.612,491.238,494.015,497.597,500.944,503.266,506.891,510.74600000000004,513.751,517.098,520.453,523.216,526.841,529.618" y="131.75900000000001" svg_rhmargin="530.801" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">colorectal adenocarcinoma: a study of 356 surgically resected cases.</text>
  <text x="319.758,324.388,328.019,332.05,335.453,337.781,341.74,343.99,348.583,351.987,354.763,357.091,359.34,363.299,366.931,370.89,373.218,376.85,379.116,383.07,384.723,388.678,392.76,396.045,397.228,400.298,403.882,407.509,411.093,414.719,416.073,419.699,423.283,424.637,428.264,431.833" y="140.774" svg_rhmargin="435.246" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Hepato-Gastroenterology. 2010;57:734</text>
  <text x="435.467" y="140.774" svg_rhmargin="439.029" style="fill:#131413;font-family:ILNNAP+PmmnvnAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="439.207,442.836,446.408" y="140.774" svg_rhmargin="447.591" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">40.</text>
  <text x="304.732,308.145,309.328,319.758,323.022,326.805,330.218,333.631,337.414,340.599,344.382,346.52,350.004,355.49,356.673,358.824,362.088,365.871,369.284,372.469,376.252,379.437,383.22,385.358,388.842,390.025,392.162,396.907,398.168,402.764,406.547,410.33,414.114,417.968,421.752,425.457,428.87,431.05,435.645,439.208,440.391,442.499,447.985,451.17,454.284,457.547,462.663,466.076,469.488,473.272,476.685,479.799,481.957,485.22,486.403,488.533,492.538,496.321,500.104,502.178,505.961,509.075,511.212,514.774,520.261" y="150.07399999999996" svg_rhmargin="521.444" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">3. Sheehan KM, Sheahan K, O'Donoghue DP, MacSweeney F, Conroy RM,</text>
  <text x="319.758,323.022,324.504,326.655,329.47,333.324,336.737,338.81,341.995,343.477,347.332,349.462,354.058,356.502,357.685,359.836,365.322,369.027,371.101,373.174,376.359,379.47299999999996,381.66,384.923,388.186,389.36899999999997,391.464,394.727,398.51,401.923,404.103,406.176,409.589,411.071,414.256,416.408,417.89,421.673,425.456,428.05,431.833,433.315,437.17,439.307,443.162,446.575,448.726,453.842,457.255,460.668,464.451,466.574,469.688,472.802,475.915,477.397,481.18,484.964,488.006,491.12,494.974,498.387,502.17,505.355,507.949,511.362,513.435" y="159.08799999999997" svg_rhmargin="516.848" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Fitzgerald DJ, Murray FE. The relationship between cyclooxygenase-2</text>
  <text x="319.758,323.171,326.214,330.068,332.142,335.554,338.148,340.741,342.223,346.007,349.79,351.899,355.084,358.867,362.72200000000004,364.881,367.994,371.777,373.259,377.043,379.116,382.529,385.642,387.794,390.979,392.461,394.641,397.755,400.94,404.723,407.837,411.249,413.323,414.506,416.636,419.08,423.233,428.72,432.873,434.056,436.194,439.607,443.019,446.432,449.845,451.028,454.441,457.853,461.266,462.449,465.862,469.275,472.688" y="168.043" svg_rhmargin="476.101" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">expression and colorectal cancer. JAMA. 1999;282:1254</text>
  <text x="476.114" y="168.043" svg_rhmargin="479.676" style="fill:#131413;font-family:ILNNAP+PmmnvnAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="479.684,483.097" y="168.043" svg_rhmargin="484.28" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">7.</text>
  <text x="304.732,308.145,309.328,319.758,323.022,326.135,329.919,331.401,335.105,337.257,340.67,342.743,344.874,348.878,350.061,352.184,356.779,360.484,363.598,367.381,369.455,373.238,378.354,380.527,386.013,387.19599999999997,389.312,395.097,398.881,402.664,404.146,407.559,411.342,415.197,418.609,420.683,424.538,426.725,430.729,431.912,434.035,437.597,441.01,444.124,447.088,450.5,452.573,454.726,460.212,464.665,465.848,467.992,471.476,474.889,478.003,480.126,484.501,485.68399999999997,487.835,491.098,492.58,495.765,499.62,501.778,506.232,510.827,512.01,514.14,518.515,521.928,524.001,527.856,531.268" y="177.34299999999996" svg_rhmargin="533.861" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">4. Schluter C, Duchrow M, Wohlenberg C, Becker MH, Key G, Flad HD, Gerdes</text>
  <text x="319.758,322.202,323.385,325.487,328.75,332.533,335.946,338.126,341.24,344.653,346.135,347.617,349.747,353.602,355.675,359.458,360.94,362.422,364.275,367.688,369.761,372.946,375.098,376.58,380.363,384.146,386.22,389.404,391.998,394.591,398.375,401.488,402.97,406.155,408.307,411.72,415.57500000000005,417.776,420.961,424.744,426.896,428.378,432.232,435.645,439.428,441.53,445.314,447.166,449.353,452.538,456.322,458.473,459.955,463.81,467.593,471.448,474.56199999999995,476.677,480.161,481.643,483.717,487.13,490.542,491.72499999999997,493.856,497.041,499.185,502.37,505.783,507.856,510.96999999999997,513.128,514.61,517.795,519.869,523.723,527.136" y="186.35799999999995" svg_rhmargin="528.319" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">J. The cell proliferation-associated antigen of antibody Ki-67: a very large,</text>
  <text x="319.758,323.463,327.318,328.8,332.655,336.359,337.841,339.993,343.777,347.481,350.074,352.184,355.967,359.672,362.786,364.268,367.681,370.865,372.938,375.14,378.995,381.068,384.852,387.003,390.416,391.898,395.68100000000004,397.819,402.935,404.417,406.568,410.351,412.503,416.287,419.992,425.777,429.19,431.263,435.047,438.752,441.345,443.454,445.527,448.94,452.795,456.208,459.392,461.544,464.957,468.812,471.006,474.419,475.901,479.314,485.099,488.512,492.295,494.447,497.041,498.224,500.375,502.448,505.861,509.716,511.789,515.202,517.795,521.208,524.992,527.143,528.625,532.409" y="195.37300000000005" svg_rhmargin="536.264" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">ubiquitous nuclear protein with numerous repeated elements, representing</text>
  <text x="319.758,322.943,325.088,328.871,332.284,337.4,339.487,342.451,343.933,347.717,351.572,353.716,357.499,359.351,361.539,364.652,368.065,369.547,371.02900000000005,373.16,376.273,379.387,382.5,383.982,387.395,389.469,395.254,398.439,399.921,403.704,405.856,409.041,410.523,414.306,415.788,419.571,423.42600000000004,425.599,429.453,431.527,435.31,437.462,440.875,442.357,446.14,448.733,449.916,452.075,454.519,456.664,460.668,464.081,465.563,467.045,469.132,472.694,474.176,477.96,479.442,480.625,482.798,486.21,489.623,493.036,496.449,497.632,501.045,504.457,507.87,509.723,513.135,514.988,516.171,519.584,522.996" y="204.38800000000003" svg_rhmargin="526.409" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">a new kind of cell cycle-maintaining proteins. J Cell Biol. 1993;123(3):513</text>
  <text x="526.402" y="204.38800000000003" svg_rhmargin="529.964" style="fill:#131413;font-family:ILNNAP+PmmnvnAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="529.971,533.384,536.797" y="204.38800000000003" svg_rhmargin="537.98" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">22.</text>
  <text x="304.732,308.145,309.328,319.758,325.245,328.657,331.771,335.184,337.257,339.373,343.527,344.71,346.854,352.341,355.753,357.827,360.791,364.204,365.68600000000004,367.83,371.093,372.276,374.406,377.969,380.042,383.747,386.861,389.825,391.307,393.451,399.237,400.42,402.578,405.842,408.955,412.738,416.151,417.633,419.115,422.528,424.601,428.014,430.087,432.225,435.787,436.96999999999997,439.143,442.407,445.52,449.303,450.785,452.267,456.122,459.977,463.389,465.463,469.31800000000004,471.455,475.459,476.642,478.765,482.769,485.954,491.739,495.594,499.007,502.192,505.975,508.134,511.696" y="213.688" svg_rhmargin="512.879" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">5. Meyer A, Merkel S, Bruckl W, Schellerer V, Schildberg C, Campean V,</text>
  <text x="319.758,324.212,327.995,331.778,335.191,338.974,342.829,346.242,348.315,352.17,355.583,357.656,359.779,365.565,366.748,368.906,372.91,374.984,378.767,382.55,385.963,388.036,390.167,393.729,396.992,398.175,400.313,404.317,408.171,411.285,414.69800000000004,416.864,420.049,422.642,424.744,428.599,430.672,434.455,438.31,442.093,445.876,448.47,450.622,452.104,455.21799999999996,457.397,463.183,466.368,468.441,471.405,474.818,476.89099999999996,479.05,480.532,484.315,486.417,489.011,491.162,494.347,498.202,501.615,503.766,508.219,509.701,513.706,517.71,519.869,521.351" y="222.64300000000003" svg_rhmargin="522.833" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Hohenberger W, Croner RS. Cdc2 as prognostic marker in stage UICC II</text>
  <text x="319.758,322.872,326.655,328.137,331.921,335.704,337.841,340.955,344.14,346.213,349.327,350.809,354.592,358.375,364.161,367.346,369.939,371.122,373.274,376.537,380.242,382.315,384.438,386.882,389.027,393.031,396.216,399.999,403.113,406.526,408.599,409.782,411.933,415.346,418.759,422.172,425.585,426.768,430.18,433.593,435.446,438.859,440.711,441.894,445.307,448.719,452.132" y="231.65700000000004" svg_rhmargin="455.545" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">colon carcinomas. Eur J Cancer. 2009;45(8):1466</text>
  <text x="455.595" y="231.65700000000004" svg_rhmargin="459.157" style="fill:#131413;font-family:ILNNAP+PmmnvnAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="459.164,462.577,465.99" y="231.65700000000004" svg_rhmargin="467.173" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">73.</text>
  <text x="304.732,308.145,309.328,319.758,324.133,327.468,329.619,331.828,333.31,335.626,338.73999999999995,341.689,347.246,352.861,354.044,356.943,360.627,364.424,366.576,370.545,373.829,375.981,378.133,381.082,384.367,386.811,387.99399999999997,391.0,396.615,399.8,403.761,407.616,411.47,414.983,418.097,421.046,426.604,430.287,431.46999999999997,434.427,440.212,441.851,445.705,449.674,452.339,455.573,459.428,461.017,463.283,464.76500000000004,467.707,472.246,475.587,476.77,479.727,483.069,486.353,487.835,489.474,495.259,498.202,503.816" y="240.957" svg_rhmargin="504.999" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">6. Garrity MM, Burgart LJ, Mahoney MR, Windschitl HE, Salim M,</text>
  <text x="319.758,325.544,327.183,330.681,333.36,336.858,340.727,342.708,346.121,347.752,351.607,354.556,360.128,361.311,364.268,367.837,370.046,373.915,377.784,380.748,383.676,386.205,389.554,390.73699999999997,393.693,399.308,400.79,404.067,407.936,411.206,412.774,416.044,419.008,421.937,424.487,428.577,429.76,432.717,437.177,441.046,442.613,446.468,450.493,454.006,456.165,460.02000000000004,462.969,466.617,472.231,473.414,476.314,481.187,482.534,486.624,490.492,494.404,498.273,501.771,503.253,504.735,507.72,513.335,515.885,517.068,519.968,523.481,525.633,528.582,531.867,533.434" y="249.97199999999998" svg_rhmargin="534.617" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Wiesenfeld M, Krook JE, Michalak JC, Goldberg RM, O'Connell MJ, et al.</text>
  <text x="319.758,323.386,325.538,329.422,333.277,337.247,341.102,343.796,346.048,347.63,350.74399999999997,353.637,356.923,360.208,361.79,365.596,369.009,371.945,375.829,377.681,380.646,384.501,386.767,390.651,392.234,393.816,395.769,399.282,401.456,404.741,406.951,408.533,412.417,416.301,417.484,420.384,423.669,427.624,431.508,435.463,437.673,441.585,444.279,445.861,448.555,449.738,452.695,456.65,460.164,462.117,465.63,468.801,471.068,472.65,475.836,479.249,482.234,486.938,491.562,495.716,498.645,504.431,506.071,508.765,514.551,517.893,520.16,523.331" y="258.98699999999997" svg_rhmargin="527.114" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Prognostic value of proliferation, apoptosis, defective DNA mismatch</text>
  <text x="319.758,321.929,325.438,329.29,332.636,334.215,336.385,337.568,340.522,343.811,347.691,351.546,354.492,358.444,361.854,365.267,368.249,372.158,375.44,378.85,381.105,384.515,387.733,391.585,393.855,397.265,400.033,402.695,404.274,408.154,411.937,414.899,416.485,420.26800000000003,423.172,427.138,430.42,432.633,434.212,437.721,441.602,443.85,446.44300000000004,449.348,454.56,456.139,458.352,462.135,465.097,467.253,470.762,473.453,476.962,480.173,482.386,485.903,489.75800000000004,492.704,497.411,501.213,504.274,507.684,510.452,511.713,514.646,518.277,521.69,524.629,528.538,530.611,533.53" y="268.00199999999995" svg_rhmargin="537.534" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">repair, and p53 overexpression in patients with resected Dukes' B2 or C</text>
  <text x="319.758,322.936,326.791,328.38,332.291,336.074,338.981,342.216,345.501,349.355,352.533,356.046,358.197,359.38,362.337,365.522,368.457,372.369,376.223,378.375,380.641,384.42400000000004,387.331,390.566,394.078,397.933,400.199,402.35,405.635,407.117,410.06,414.142,417.427,421.281,424.509,428.021,430.094,433.009,435.275,437.426,440.939,444.124,446.439,452.332,455.745,459.699,461.851,464.8,468.655,470.864,474.775,478.573,482.428,485.377,488.042,490.307,494.105,497.96,501.251,502.43399999999997,505.391,507.83500000000004,510.777,514.86,516.449,517.931" y="276.957" svg_rhmargin="521.714" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">colon cancer: a north central Cancer treatment group study. J Clin</text>
  <text x="319.758,324.599,328.478,331.687,335.566,337.143,338.32599999999996,341.278,344.694,348.252,351.761,355.269,356.519,360.027,363.535,365.483,368.991,370.939,372.218,375.726,379.142,382.7" y="285.972" svg_rhmargin="386.113" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Oncol. 2004;22(9):1572</text>
  <text x="386.205" y="285.972" svg_rhmargin="389.767" style="fill:#131413;font-family:ILNNAP+PmmnvnAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="389.832,393.347,396.861" y="285.972" svg_rhmargin="398.044" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">82.</text>
  <text x="304.732,308.145,309.328,319.758,323.022,326.805,330.66,334.443,336.51599999999996,338.639,340.121,343.605,344.788,346.919,351.372,355.077,357.228,360.342,364.125,365.607,369.391,371.98400000000004,374.129,378.503,382.878,384.061,386.205,389.469,392.062,395.917,397.399,399.472,400.954,403.106,406.811,408.998,413.002,414.185,416.308,421.053,424.758,426.24,428.313,431.277,434.69,436.828,440.39,441.573,443.746,446.19,449.895,453.749,457.60400000000004,459.734,463.888,469.374,470.557,472.716,476.278,478.352,482.135,485.99,489.773,493.556,496.15,498.301,499.783,502.897,505.027,508.212,511.996" y="295.272" svg_rhmargin="515.851" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">7. Fodor IK, Hutchins GG, Espiritu C, Quirke P, Jubb AM. Prognostic and</text>
  <text x="319.758,323.613,325.686,329.099,332.954,334.436,337.549,339.701,341.183,344.368,347.781,349.918,352.512,353.994,357.848,361.632,363.114,364.966,366.448,369.562,372.746,376.53,379.643,383.056,385.236,389.02,390.87199999999996,393.003,396.857,398.93,402.714,404.196,405.678,407.53,410.943,413.016,416.201,418.353,419.835,423.618,427.401,429.567,431.049,434.832,436.935,440.347,443.76,447.173,449.296,452.41,456.193,457.675,461.459,463.532,466.945,470.058,472.21,475.395,476.877,479.057,482.171,485.355,489.139,492.252,495.665,497.739,500.332,501.515,503.659,506.103,508.248,512.252,513.734,515.216" y="304.286" svg_rhmargin="518.999" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">predictive significance of proliferation in 867 colorectal cancers. J Clin</text>
  <text x="319.758,323.321,326.506,328.657,332.441,336.224,337.706,338.889,341.019,344.432,347.845,351.258,354.671,355.853,359.266,362.679,364.531,367.944,371.357,373.21,374.392,377.805,381.218" y="313.301" svg_rhmargin="384.631" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Pathol. 2012;65(11):989</text>
  <text x="384.616" y="313.301" svg_rhmargin="388.178" style="fill:#131413;font-family:ILNNAP+PmmnvnAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="388.186,391.599,395.012" y="313.301" svg_rhmargin="396.195" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">95.</text>
  <text x="304.732,308.145,309.328,319.758,323.022,326.207,327.688,333.474,334.956,338.739,342.152,345.935,348.044,351.308,352.491,354.621,358.183,361.368,362.85,368.635,372.34,374.52,377.784,378.967,381.097,384.659,387.844,391.627,393.109,396.964,400.377,402.45,406.305,408.478,411.741,412.924,415.054,418.617,422.4,426.254,429.667,431.741,433.892,436.485,438.638,442.2,444.644,445.827,447.936,451.199,454.982,458.837,462.25,464.323,466.916,469.068,471.141,474.925,480.71000000000004,482.912,486.396,491.141,492.324,494.418,495.9,499.684,502.797,504.871,508.284,511.468,514.062,517.475" y="322.601" svg_rhmargin="521.33" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">8. Salminen E, Palmu S, Vahlberg T, Roberts PJ, Soderstrom KO. Increased</text>
  <text x="319.758,323.613,325.686,329.47,330.952,332.434,334.286,337.699,339.772,342.957,345.109,346.591,350.374,354.15700000000004,356.266,359.451,362.565,364.717,366.199,369.383,370.865,373.017,376.131,378.318,384.103,387.516,390.701,393.295,397.0,399.073,402.486,406.341,408.478,412.332,415.44599999999997,417.605,419.087,424.872,430.658,434.363,438.146,441.929,444.003,447.415,450.6,453.714,455.866,457.348,460.532,463.945,466.076,469.56,471.042,474.454,477.867,480.019,481.501,484.094,486.253,489.438,492.032,494.625,498.408,501.522,503.004,506.189,508.341,511.753,515.608,517.774,522.89,524.372,526.523" y="331.556" svg_rhmargin="530.306" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">proliferation activity measured by immunoreactive Ki67 is associated with</text>
  <text x="319.758,322.352,326.057,328.13,331.315,332.797,335.982,339.167,340.649,342.772,344.254,350.039,353.894,355.967,359.751,362.935,366.348,372.134,375.547,379.33,381.48199999999997,383.648,385.129,388.91200000000003,391.072,393.145,396.558,399.671,401.823,405.008,406.49,408.934,411.007,414.42,417.534,419.685,423.468,425.599,428.192,429.674,433.529,439.314,443.098,444.58,448.435,450.6,453.714,456.899,460.682,463.796,467.208,469.282,470.465,472.595,478.38,482.164,484.237,485.719,489.574,491.754,494.19800000000004,496.342,500.717,503.902,506.495,508.647,510.72,514.504,517.916,521.7,523.851,527.264,529.338,533.121,534.603" y="340.571" svg_rhmargin="535.786" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">survival improvement in rectal/recto sigmoid cancer. World J Gastroenterol.</text>
  <text x="319.758,323.171,326.584,329.997,333.41,334.593,338.005,341.418,343.271,346.684,350.096,351.949,353.132,356.544,359.957,363.37" y="349.586" svg_rhmargin="366.783" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">2005;11(21):3245</text>
  <text x="366.754" y="349.586" svg_rhmargin="370.316" style="fill:#131413;font-family:ILNNAP+PmmnvnAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="370.324,373.737" y="349.586" svg_rhmargin="374.92" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">9.</text>
  <text x="304.732,308.145,309.328,319.758,323.542,327.325,330.51,334.293,338.148,340.278,344.062,345.245,347.367,353.153,356.338,360.121,363.976,366.135,371.621,372.804,374.977,378.76,382.543,386.327,390.032,392.155,395.34,396.52299999999997,398.674,401.937,405.35,409.133,412.988,415.111,418.966,420.149,422.307,426.312,430.095,433.508,437.291,441.146,443.283,445.727,446.90999999999997,449.069,452.631,456.33599999999996,458.481,462.043,463.226,465.342,469.716,473.5,477.283,481.13800000000003,483.254,486.816,487.99899999999997,490.172,493.955,497.739,501.44399999999996,503.61,507.172,508.355,510.471,513.656,515.1379999999999,517.275,521.279,522.462,524.585,527.849,529.331,532.515" y="358.886" svg_rhmargin="536.298" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">9. Zhang Z, Wang M, Zhou L, Feng X, Cheng J, Yu Y, Gong Y, Zhu Y, Li C, Tian</text>
  <text x="319.758,322.943,324.126,326.221,329.634,331.786,333.93,337.115,338.597,339.78,341.924,343.406,347.189,350.303,352.376,355.789,358.974,361.567,364.98,368.83500000000004,371.008,375.461,380.947,385.322,388.884,392.297,394.42,397.605,401.389,405.244,407.402,410.516,411.998,415.41,418.595,421.78,425.193,429.048,431.213,434.327,437.512,440.105,443.96,447.145,449.738,453.151,455.224,458.637,460.803,463.397,465.548,467.03,472.816,476.521,478.003,481.188,483.339,486.752,488.925,491.077,494.86,498.273,500.375,504.23,506.303,510.086,511.568,513.05,514.903,518.316,520.389,523.574,525.725,527.207,530.991" y="367.901" svg_rhmargin="534.774" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">L, et al. Increased HMGB1 and cleaved caspase-3 stimulate the proliferation</text>
  <text x="319.758,323.542,325.39399999999995,327.525,329.676,333.381,339.167,342.95,345.02299999999997,347.139,350.253,353.666,355.148,356.63,359.223,361.368,364.553,368.336,372.19100000000003,374.349,377.534,379.608,383.021,385.179,388.293,392.076,394.15,396.223,399.636,401.118,404.303,406.454,409.867,413.72200000000004,415.852,420.968,422.45,424.601,428.384,430.537,432.688,436.472,439.885,442.043,445.898,449.681,453.465,455.53799999999995,457.69,461.544,463.617,467.401,471.255,475.039,478.822,481.416,482.897,485.49,487.621,489.103,492.886,495.045,498.159,501.942,503.424,507.208,509.281,512.694,515.807,517.959,521.144" y="376.855" svg_rhmargin="522.626" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">of tumor cells and are correlated with the poor prognosis in colorectal</text>
  <text x="319.758,322.872,326.057,329.84,332.954,336.367,338.44,339.623,341.753,344.197,346.341,349.605,352.647,356.502,358.646,362.65,364.132,365.614,369.397,371.514,375.518,378.703,382.486,385.6,389.013,391.08599999999996,393.223,396.786,400.199,402.792,403.97499999999997,406.148,409.561,412.974,416.386,419.799,420.982,424.395,427.808,428.99,432.403,435.816" y="385.87" svg_rhmargin="436.999" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">cancer. J Exp Clin Cancer Res. 2015;34:51.</text>
  <text x="304.732,308.145,311.558,312.741,319.758,323.321,327.104,329.698,333.481,334.963,340.748,344.453,346.527,349.712,351.849,356.302,357.485,359.615,364.211,367.994,371.179,373.25199999999995,375.432,380.028,383.512,384.695,386.825,391.349,394.534,397.498,400.683,406.469,410.252,412.404,416.187,418.346,421.609,422.792,424.922,428.406,432.189,434.341,438.125,441.908,444.024,447.287,448.46999999999997,450.657,453.92,457.105,460.069,463.254,467.037,470.82,472.937,478.423,479.606,481.779,485.042,488.825,494.611,497.796,499.919,504.294,505.477,507.628,512.152,515.337,519.192,522.377,524.97,528.675" y="395.17" svg_rhmargin="532.088" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">10. Yoshimura H, Dhar DK, Nakamoto T, Kotoh T, Takano M, Soma G, Nagasue</text>
  <text x="319.758,324.283,325.466,327.582,331.144,333.217,337.001,340.855,344.639,348.422,351.015,353.167,354.649,357.763,359.893,362.487,363.968,367.823,371.606,373.088,374.941,376.423,379.536,382.721,386.505,389.618,393.031,395.211,398.995,400.847,402.977,405.129,408.834,414.619,418.403,420.476,422.649,426.433,429.845,432.959,435.032,438.816,441.409,442.891,445.48400000000004,447.594,449.446,452.631,455.744,457.896,461.679,463.75199999999995,465.905,467.978,471.391,474.504,477.917,481.772,483.923,487.707,489.78,491.925,493.407,497.19,499.349,502.462,506.246,507.728,511.511,513.584,516.997,520.111,522.263,525.447" y="404.185" svg_rhmargin="526.929" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">N. Prognostic significance of tumor necrosis factor receptor in colorectal</text>
  <text x="319.758,322.943,326.798,330.211,333.994,337.777,340.891,344.076,346.149,349.263,350.745,354.528,358.311,364.097,367.282,368.465,370.609,374.763,378.546,380.698,382.18,385.293,388.478,392.262,395.375,398.788,400.861,403.034,406.597,410.01,412.603,413.786,415.902,419.315,422.728,426.141,429.553,430.736,434.149,437.562,439.414,442.827,446.981,448.833,450.016,453.429" y="413.2" svg_rhmargin="456.842" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">adenocarcinoma. Anticancer Res. 2003;23(1A):85</text>
  <text x="456.842" y="413.2" svg_rhmargin="460.404" style="fill:#131413;font-family:ILNNAP+PmmnvnAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="460.411,463.824" y="413.2" svg_rhmargin="465.007" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">9.</text>
  <text x="304.732,308.145,311.558,312.741,319.758,322.943,324.425,326.563,331.158,336.944,338.127,340.285,343.549,346.733,350.517,354.372,356.502,360.955,366.441,367.62399999999997,369.768,373.031,376.216,379.999,382.13,384.574,390.359,391.542,393.694,397.256,400.441,404.224,406.39,410.986,416.771,417.954,420.056,423.839,427.622,431.406,435.111,437.291,441.295,445.078,446.26099999999997,448.399,451.584,453.06600000000003,455.203,458.466,462.321,463.504,465.634,471.419,474.604,478.387,482.242,484.401,488.255,491.44,492.623,494.775,498.337,501.75,505.533,509.38800000000003,511.554,515.337,519.79" y="422.5" svg_rhmargin="520.973" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">11. Li DW, Tang HM, Fan JW, Yan DW, Zhou CZ, Li SX, Wang XL, Peng ZH.</text>
  <text x="319.758,323.022,326.064,329.919,331.992,335.405,337.998,340.592,342.074,345.857,349.64000000000004,351.792,353.274,356.687,359.872,363.285,364.76700000000005,366.868,370.652,372.50399999999996,374.691,378.254,384.039,385.521,387.595,391.00800000000004,393.116,396.9,400.683,403.797,407.58,411.435,413.508,417.291,419.443,422.856,424.338,428.12100000000004,430.251,431.733,434.326,436.486,439.671,442.264,444.858,448.641,451.754,453.236,456.421,458.573,461.986,465.841,468.006,473.122,474.604,476.756,480.539,482.691,486.545,488.619,492.402,496.257,498.33,501.743,504.336,506.93,508.412,512.195,515.9780000000001,518.123,521.308,525.091" y="431.455" svg_rhmargin="528.946" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Expression level of Bmi-1 oncoprotein is associated with progression and</text>
  <text x="319.758,323.613,325.686,329.47,333.324,337.108,340.891,343.484,344.966,347.559,349.69,351.172,354.95500000000004,357.114,360.228,364.011,365.493,369.277,373.06,375.197,378.311,381.496,385.279,388.393,391.806,393.879,395.062,397.192,399.636,401.78,405.785,408.969,412.753,415.866,419.279,421.352,423.49,427.052,430.465,433.058,435.225,439.229,440.711,442.193,445.976,448.092,452.837,456.621,459.734,463.518,465.0,466.183,468.334,471.747,475.16,478.573,481.985,483.168,486.581,489.994,493.407,495.259,498.672,500.524,501.707,505.12,508.533" y="440.47" svg_rhmargin="511.946" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">prognosis in colon cancer. J Cancer Res Clin Oncol. 2010;136(7):997</text>
  <text x="512.003" y="440.47" svg_rhmargin="515.565" style="fill:#131413;font-family:ILNNAP+PmmnvnAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="515.515,518.928,522.341,525.754,529.166" y="440.47" svg_rhmargin="530.349" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">1006.</text>
  <text x="304.732,308.145,311.558,312.741,319.758,322.943,324.425,326.563,331.158,332.341,334.5,338.062,341.475,345.259,349.11400000000003,351.222,355.077,356.26,358.418,361.981,365.166,368.949,371.058,375.653,376.836,378.995,382.258,385.443,389.226,393.081,395.211,399.664,400.847,402.977,407.43,411.135,414.32,418.104,421.959,424.124,427.387,428.57,430.7,434.263,437.448,441.231,445.086,447.252,450.814,451.997,454.113,457.675,461.088,464.871,468.726,470.892,474.675,475.858,477.981,483.467,486.061,487.543,489.616,493.029,495.216,496.698,499.291,501.394,504.579,506.723,510.578,512.651,516.064,519.918,521.4,524.514,526.666,530.449" y="449.77" svg_rhmargin="532.522" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">12. Li D, Peng X, Yan D, Tang H, Huang F, Yang Y, Peng Z. Msi-1 is a predictor</text>
  <text x="319.758,323.542,325.39399999999995,327.525,330.118,333.823,335.896,339.081,340.563,343.748,346.933,348.415,350.538,353.723,357.506,361.361,363.52,366.705,368.849,372.632,376.416,379.601,383.013,384.495,386.647,388.799,392.582,395.995,398.068,401.253,405.108,408.521,412.226,414.377,415.859,418.97299999999996,421.117,423.269,426.454,428.527,432.382,435.795,437.947,440.112,441.594,445.377,447.537,450.65,454.434,455.915,459.699,463.482,465.62,468.733,471.918,475.701,478.815,482.228,484.301,485.484,487.614,491.768,495.551,499.334,501.501,504.764,508.469,510.542,514.3969999999999,516.527,521.272,525.056,528.169,531.953,533.435" y="458.784" svg_rhmargin="534.618" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">of survival and a novel therapeutic target in colon cancer. Ann Surg Oncol.</text>
  <text x="319.758,323.171,326.584,329.997,333.41,334.593,338.005,341.418,343.271,346.684,348.536,349.719,353.132,356.544,359.957" y="467.799" svg_rhmargin="363.37" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">2011;18(7):2074</text>
  <text x="363.356" y="467.799" svg_rhmargin="366.918" style="fill:#131413;font-family:ILNNAP+PmmnvnAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="366.925,370.338,373.751" y="467.799" svg_rhmargin="374.934" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">83.</text>
  <text x="304.732,308.145,311.558,312.741,319.758,324.354,327.696,332.911,335.576,339.487,343.27000000000004,346.178,350.716,351.899,354.856,358.425,362.337,365.75,367.381,370.331,373.744,375.817,378.831,382.458,386.996,388.179,391.136,394.705,397.99,400.142,403.426,409.319,410.907,413.116,416.971,420.939,424.794,428.591,430.18,434.092,437.79699999999997,440.725,444.067,445.25,448.206,451.548,454.783,458.637,462.492,466.403,472.189,476.157,479.86199999999997,482.791,488.348,489.531,492.488,497.026,500.311,506.203,511.989,515.558,517.631,520.603,524.685" y="477.099" svg_rhmargin="525.868" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">13. Dawson H, Koelzer VH, Karamitopoulou E, Economou M, Hammer C,</text>
  <text x="319.758,325.339,329.138,330.714,332.29,335.704,337.777,340.793,345.496,348.854,350.037,352.995,356.181,360.023,363.971,365.547,367.02900000000005,369.966,374.221,375.404,378.362,382.218,383.794,387.672,391.62,395.034,398.14799999999997,401.149,402.739,403.92199999999997,406.88,410.223,414.101,417.514,420.45,423.729,427.678,431.555,435.504,437.714,441.627,443.837,445.427,448.541,451.492,454.778,458.655,462.51,465.461,469.317,471.584,475.462,477.038,478.614,480.56,484.067,486.234,489.513,491.723,493.299,497.177,500.96000000000004,503.926,506.079,509.358,511.603,515.016,517.953,521.809" y="486.114" svg_rhmargin="523.661" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Muller DE, Lugli A, Zlobec I. The apoptotic and proliferation rate of</text>
  <text x="319.758,321.998,325.79,331.685,335.542,339.334,341.407,344.381,348.237,352.094,356.065,360.035,361.52,365.483,369.338,372.282,375.484,378.984,380.554,382.038,384.63100000000003,387.64,389.224,393.007,395.916,399.146,403.017,404.587,408.458,410.668,414.083,417.363,419.631,422.818,424.3,427.287,430.517,433.789,437.66,440.89,444.305,446.378,449.394,453.251,457.044,459.312,460.881,462.365,466.329,469.844,472.437,475.339,478.524,481.461,485.375,488.79,491.101,494.615,496.776,500.647,504.618,508.133,512.004,515.504,519.375,523.168" y="495.069" svg_rhmargin="525.761" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">tumour budding cells in colorectal cancer outlines a heterogeneous</text>
  <text x="319.758,323.611,327.577,331.43,335.282,336.862,340.144,342.358,343.945,347.826,351.60900000000004,354.571,358.452,360.304,363.273,366.484,369.895,371.524,373.111,375.704,378.609,383.823,385.402,387.651,391.434,394.34,397.622,400.904,403.075,404.655,408.536,412.339,414.932,417.894,419.473,425.257,429.28,432.57,435.745,438.016,440.60900000000004,443.571,447.424,451.207,454.169,457.344,458.924,460.503,464.384,465.964,469.139,472.422,473.90400000000005,476.844,480.725,484.528,486.742,489.974,493.855,499.738,503.149" y="504.084" svg_rhmargin="504.332" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">population of cells with various impacts on clinical outcome.</text>
  <text x="319.758,324.311,325.793,328.565,330.774,334.657,338.511,341.853,344.118,348.001,351.885,353.466,357.349,361.304,364.517,365.7,368.6,372.112,375.625,379.137,382.65,383.897,387.409,390.922,392.874,396.387,398.339,399.621,403.034,406.597" y="513.0989999999999" svg_rhmargin="410.01" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Histopathology. 2014;64(4):577</text>
  <text x="410.074" y="513.0989999999999" svg_rhmargin="413.636" style="fill:#131413;font-family:ILNNAP+PmmnvnAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="413.7,417.215,420.73" y="513.0989999999999" svg_rhmargin="421.913" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">84.</text>
  <text x="304.739,308.152,311.565,312.748,319.766,325.551,328.964,332.818,336.231,338.304,340.399,342.843,346.847,348.03,350.203,354.728,357.912,360.876,364.061,367.845,371.62800000000004,373.787,378.24,379.423,381.553,385.115,388.3,391.414,395.197,398.61,400.092,401.574,403.056,406.469,408.542,410.694,414.256,415.43899999999996,417.555,422.3,426.005,428.599,431.192,434.975,438.68,440.162,442.314,445.128,448.912,452.766,454.248,458.032,461.73699999999997,463.931,467.194,468.377,470.507,471.989,475.773,479.556,483.261,486.67400000000004,488.818,492.302,493.485,495.623,498.886,502.669,504.151,509.936,513.641,515.715,518.9,521.08,525.533" y="522.399" svg_rhmargin="526.716" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">14. Weber JC, Nakano H, Bachellier P, Oussoultzoglou E, Inoue K, Shimura H,</text>
  <text x="319.766,325.551,329.334,330.816,332.66799999999995,334.792,338.354,339.537,341.653,345.657,349.441,352.854,356.637,359.822,361.895,365.75,367.823,372.347,375.76,379.465,381.674,387.16,390.722,391.905,394.036,396.479,399.664,403.077,406.191,409.155,411.271,415.866,417.049,419.208,420.69,423.283,425.442,428.627,430.772,434.626,436.699,440.483,441.965,443.447,445.299,448.712,450.785,453.97,456.122,457.604,461.387,465.17,467.337,468.819,472.602,476.456,479.869,482.911,485.021,488.804,490.65599999999995,492.787,495.9,499.085,502.868,505.982,509.395,511.46799999999996,513.648,516.762,520.175,521.657,523.139,525.732,527.877" y="531.413" svg_rhmargin="531.062" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Wolf P, Chenard-Neu MP, Jaeck D. Is a proliferation index of cancer cells a</text>
  <text x="319.766,321.839,325.252,326.734,328.216,331.401,335.255,336.737,340.15000000000003,342.273,346.128,348.201,351.984,355.839,359.622,363.406,365.999,368.151,369.633,372.74699999999996,374.927,376.779,379.964,383.077,385.229,389.013,391.08599999999996,393.238,396.422,398.275,400.427,403.84,405.91299999999995,408.036,411.819,415.232,419.087,422.272,424.423,427.836,430.95,433.102,436.885,442.67,445.784,447.95,449.432,453.21500000000003,455.374,459.229,462.413,464.565,466.047,469.46,473.243,475.395,477.988,480.09,485.206,486.688,488.84,492.623,494.775,497.888,501.672,503.154,506.937,509.01,512.423,515.537,517.688,520.873,522.355,524.536,526.018,527.5,530.684,534.097" y="540.3679999999999" svg_rhmargin="536.17" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">reliable prognostic factor after hepatectomy in patients with colorectal liver</text>
  <text x="319.766,325.551,328.964,331.116,334.3,336.894,339.046,342.23,344.824,348.237,350.83,353.502,355.654,359.808,365.593,367.731,370.175,372.319,375.582,379.287,381.361,385.215,386.39799999999997,388.535,391.948,395.361,398.774,402.187,403.369,406.782,410.195,413.608,415.46,418.873,420.726,421.908,425.321" y="549.383" svg_rhmargin="428.734" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">metastases? Am J Surg. 2001;182(1):81</text>
  <text x="428.734" y="549.383" svg_rhmargin="432.296" style="fill:#131413;font-family:ILNNAP+PmmnvnAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="432.303,435.716" y="549.383" svg_rhmargin="436.899" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">8.</text>
  <text x="304.746,308.16,311.573,312.756,319.768,323.623,325.105,328.105,332.659,337.504,338.687,341.588,345.5,349.384,352.669,356.452,359.417,363.044,364.227,367.185,371.268,372.85,374.433,378.316,379.899,383.07,386.954,390.809,394.152,396.418,400.302,404.186,405.768,409.652,413.607,415.189,418.361,421.646,423.12800000000004,426.064,428.758,430.241,434.26,438.115,439.697,441.65,443.233,446.447,449.732,453.616,456.787,460.2,463.136,466.421,470.305,474.16,477.11,480.965,483.139,487.023,490.878,494.848,498.731,501.425,503.677,505.26,508.37399999999997,511.324,514.509,517.845,519.434,523.24,526.653,529.589,533.472" y="558.683" svg_rhmargin="535.324" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">15. Xi HQ, Zhao P. Clinicopathological significance and prognostic value of</text>
  <text x="319.773,323.122,326.977,330.947,335.201,338.61400000000003,341.55,344.835,348.705,352.56,355.51,359.6,364.303,367.802,371.216,374.629,377.608,381.121,384.249,388.219,390.378,393.877,396.557,399.279,400.848,404.717,408.5,411.408,412.998,416.781,419.746,422.917,426.829,428.312,432.274,434.426,437.925,441.125,443.392,446.677,448.15900000000005,451.102,454.274,457.545,459.704,462.932,464.522,468.392,472.261,478.154,481.425,482.608,485.565,488.009,490.953,495.036,496.604,498.172,501.95500000000004,504.863,508.547,511.733,514.049,517.905,521.817,523.299" y="567.698" svg_rhmargin="524.482" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">EphA3 and CD133 expression in colorectal carcinoma. J Clin Pathol.</text>
  <text x="319.773,323.184,326.745,330.256,333.767,335.013,338.524,342.035,343.986,347.497,349.448,350.729,354.24,357.651" y="576.713" svg_rhmargin="361.064" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">2011;64(6):498</text>
  <text x="361.218" y="576.713" svg_rhmargin="364.78" style="fill:#131413;font-family:ILNNAP+PmmnvnAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="364.902,368.315,371.877,375.39" y="576.713" svg_rhmargin="376.573" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">503.</text>
  <text x="304.753,308.166,311.579,312.762,319.78,321.262,324.447,327.632,331.415,334.828,337.941,340.755,342.907,347.061,348.24399999999997,350.388,353.873,357.057,360.242,363.427,364.909,368.094,370.167,372.326,375.888,377.07099999999997,379.187,382.75,385.935,387.417,389.269,392.383,394.549,400.035,401.218,403.334,406.896,408.378,411.563,414.976,418.09,420.227,423.789,424.972,427.145,430.408,432.482,435.894,441.68,445.093,448.207,450.329,455.816,456.99899999999997,459.172,463.625,467.408,469.481,472.666,475.851,478.003,480.147,485.633,486.816,488.932,492.495,496.278,498.43,500.503,503.61699999999996,505.768,509.032,510.215,512.345,516.349,519.534,523.317,525.497,530.613" y="586.013" svg_rhmargin="534.026" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">16. Ivanecz A, Kavalar R, Palfy M, Pivec V, Sremec M, Horvat M, Potrc S. Can we</text>
  <text x="319.78,321.262,327.047,330.902,332.975,336.758,339.943,343.356,345.458,347.61,351.393,354.806,356.965,360.078,361.56,363.042,366.826,368.308,371.421,374.606,376.088,378.225,380.299,381.781,384.374,387.338,389.504,392.098,395.211,398.994,401.068,404.481,407.153,409.29,412.553,416.337,419.75,421.873,425.727,427.801,431.584,435.438,439.222,443.005,445.599,447.75,449.232,452.346,454.526,457.711,460.896,462.378,466.083,469.49600000000004,471.647,475.431,477.28299999999996,479.413,483.268,486.681,490.094,491.277,493.414,496.898,498.38,500.453,503.866,507.279,509.459,512.644,516.427" y="594.968" svg_rhmargin="520.282" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">improve the clinical risk score? The prognostic value of p53, Ki-67 and</text>
  <text x="319.78,321.932,325.715,328.828,334.614,336.096,339.95,343.064,344.546,347.731,349.883,353.296,355.44,358.033,361.147,364.93,367.082,370.865,374.05,376.644,380.057,382.201,383.683,387.466,389.625,393.48,396.665,398.816,400.298,403.711,407.495,409.646,412.23900000000003,414.342,418.047,421.83,425.685,429.097,431.171,435.025,438.809,440.291,444.074,447.92900000000003,450.116,452.189,455.374,459.229,460.711,463.824,467.009,468.49100000000004,470.636,472.709,476.122,478.715,482.128,485.242,487.393,488.875,492.659,496.442,498.587,502.37,504.222,506.353,509.466,513.25,514.732,518.515,520.588,524.001,527.115,529.266,532.451" y="603.982" svg_rhmargin="533.933" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">thymidylate synthase in patients undergoing radical resection of colorectal</text>
  <text x="319.78,321.262,322.744,325.929,329.341,331.414,333.552,339.338,342.751,344.902,348.087,350.681,352.832,356.017,358.611,362.023,364.617,365.8,367.966,372.419,375.981,379.544,381.688,383.541,388.286,391.328,393.181,396.964,399.037,402.892,404.744,405.927,408.05,411.463,414.876,418.289,421.702,422.884,426.297,429.71,431.563,434.975,436.828,438.011,441.423,444.836" y="612.9970000000001" svg_rhmargin="448.249" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">liver metastases. HPB (Oxford). 2014;16(3):235</text>
  <text x="448.249" y="612.9970000000001" svg_rhmargin="451.811" style="fill:#131413;font-family:ILNNAP+PmmnvnAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="451.818,455.231,458.644" y="612.9970000000001" svg_rhmargin="459.827" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">42.</text>
  <text x="304.761,308.171,311.582,312.765,319.781,323.127,326.702,329.115,332.119,334.048,335.53000000000003,337.281,341.475,342.658,344.423,348.247,351.85,353.151,356.156,359.089,361.98,365.583,366.828,370.611,372.383,375.73,376.913,378.677,382.024,385.256,388.931,392.562,393.864,396.868,398.762,402.436,406.219,407.934,412.129,413.312,415.076,419.492,422.90500000000003,424.591,427.674,430.678,434.281,437.215,439.143,440.445,443.038,444.754,449.176,450.359,452.124,457.394,460.398,464.002,466.636,467.937,471.54,475.143,478.556,480.3,483.304,484.48699999999997,486.252,489.335,492.938,495.871,501.476,502.721,506.403,509.336,510.638,513.585,515.571" y="622.297" svg_rhmargin="518.984" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">17. Rosati G, Chiacchio R, Reggiardo G, De Sanctis D, Manzione L. Thymidylate</text>
  <text x="319.787,322.186,325.133,328.722,330.708,334.297,337.287,339.686,343.099,344.842,348.061,350.908,354.59,356.462,359.68,362.115,364.513,365.801,369.39,373.021,374.204,375.912,379.593,382.812,386.03,387.21299999999997,388.921,392.602,395.521,396.809,398.687,401.906,403.089,404.853,408.143,409.43,411.309,414.527,417.94,419.684,422.674,426.263,430.118,431.875,435.507,438.725,442.13800000000003,443.881,445.169,448.952,450.667,453.615,457.189,458.477,462.065,463.994,467.17,470.117,472.103,475.093,476.57500000000005,478.269,481.217,484.221,487.81,490.757,493.976,495.855,497.038,498.802,500.674,503.892,505.18,508.17,510.156,511.443,515.032,518.657,521.034,524.623,525.91,529.592" y="631.312" svg_rhmargin="532.185" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">synthase expression, p53, bcl-2, Ki-67 and p27 in colorectal cancer: relationships</text>
  <text x="319.787,324.722,325.966,327.936,331.719,333.434,335.405,338.929,344.533,348.135,350.20799999999997,351.93,353.858,357.033,359.98,363.504,365.396,367.289,370.52,374.123,377.055,380.468,382.154,385.158,388.76,392.615,394.315,396.727,400.251,402.144,405.147,406.448,409.452,412.456,413.7,414.883,416.647,419.708,423.232,428.836,432.439,435.963,438.036,439.814,443.16,444.461,448.064,449.365,450.548,452.311,455.543,458.718,461.95,465.182,466.184,469.415,472.59,474.29" y="640.267" svg_rhmargin="477.703" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">with tumor recurrence and survival. Tumour Biol. 2004;25(5</text>
  <text x="477.511" y="640.267" svg_rhmargin="481.073" style="fill:#131413;font-family:ILNNAP+PmmnvnAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="480.852,484.083,485.753,486.753,489.984,493.214" y="640.267" svg_rhmargin="496.627" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">6):258</text>
  <text x="496.385" y="640.267" svg_rhmargin="499.947" style="fill:#131413;font-family:ILNNAP+PmmnvnAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="499.783,503.014,506.246" y="640.267" svg_rhmargin="507.429" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">63.</text>
  <text x="304.761,308.173,311.586,312.769,319.787,324.311,325.793,328.387,332.17,333.652,337.435,340.62,342.694,345.879,348.016,351.5,352.683,354.82,358.083,361.867,365.65,371.435,375.219,377.292,378.774,380.897,384.381,385.56399999999996,387.759,391.022,394.207,399.992,403.697,405.77,408.955,411.114,414.377,415.56,417.69,420.954,424.659,426.14,427.622,431.406,434.37,437.555,439.685,442.948,444.131,446.261,451.006,454.861,458.046,463.161,466.346,468.541,471.804,472.98699999999997,475.117,476.599,478.751,482.534,484.643,489.096" y="649.567" svg_rhmargin="490.279" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">18. Nishihara K, Shomori K, Tamura T, Fujioka S, Ogawa T, Ito H.</text>
  <text x="319.787,321.269,327.054,332.84,336.545,340.328,344.111,347.895,349.377,351.97,354.122,357.905,361.019,364.802,368.215,374.0,375.482,378.596,381.781,383.26300000000003,385.379,388.792,391.834,395.689,397.762,401.175,403.768,406.362,407.844,411.627,415.41,417.576,421.36,423.212,425.342,429.197,432.61,438.395,439.877,443.661,445.143,448.926,451.078,452.56,456.343,458.502,461.615,465.399,466.881,470.664,472.737,476.15,479.264,481.415,484.6,486.08200000000005,488.205,491.319,494.504,498.287,501.401,504.814,506.887" y="658.582" svg_rhmargin="508.07" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Immunohistochemical expression of geminin in colorectal cancer:</text>
  <text x="319.787,321.269,327.054,330.909,332.391,333.873,336.986,340.171,342.323,343.805,347.588,351.37100000000004,353.516,357.3,359.152,361.282,365.137,367.21,370.994,374.848,378.632,382.415,385.008,387.16,388.642,391.756,393.879,396.472,397.954,401.809,405.592,407.074,408.927,410.409,413.522,416.707,420.49,423.604,427.017,428.2,430.387,435.132,438.915,442.029,445.812,447.29400000000004,449.432,452.994,456.407,460.262,461.445,463.603,467.016,470.429,473.842,477.255,478.437,481.85,485.263,487.115,490.528,492.381,493.563,496.976,500.389,503.802" y="667.597" svg_rhmargin="507.215" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">implication of prognostic significance. Oncol Rep. 2009;21(5):1189</text>
  <text x="507.215" y="667.597" svg_rhmargin="510.777" style="fill:#131413;font-family:ILNNAP+PmmnvnAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="510.784,514.197,517.61" y="667.597" svg_rhmargin="518.793" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">95.</text>
  <text x="304.761,308.173,311.586,312.769,319.787,323.05,326.164,329.947,333.802,336.987,339.117,343.121,347.717,348.9,351.023,354.286,356.879,360.064,365.85,369.034,372.818,376.672,379.857,382.45000000000005,384.638,388.792,392.796,393.979,396.088,399.871,403.654,405.136,408.92,411.071,414.25600000000003,416.436,419.999,421.182,423.298,426.782,429.967,431.449,435.232,437.084,440.868,444.651,448.434,451.02700000000004,453.172,457.625,461.188,462.371,464.508,468.071,471.255,473.407,474.889,477.483,479.634,482.819,484.971,488.754,492.459,494.611,498.765,499.948,502.092,505.654,508.839,512.694,514.176,517.361,521.144,524.927,527.52,529.701,533.705" y="676.896" svg_rhmargin="534.888" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">19. Scopa CD, Tsamandas AC, Zolota V, Kalofonos HP, Batistatou A, Vagianos C.</text>
  <text x="319.787,323.349,327.133,329.284,332.697,336.481,338.632,340.114,343.299,344.781,346.883,348.956,352.74,354.222,357.635,359.807,363.591,365.443,367.574,371.428,374.542,376.024,378.097,381.51,383.676,386.861,390.644,394.499,396.6,399.564,401.046,403.12,406.533,409.946,412.133,415.546,418.588,422.443,424.516,427.929,430.522,433.116,434.598,438.381,442.164,444.273,447.458,451.241,455.096,457.255,460.44,464.294,468.078,471.932,474.084,477.867,480.461,481.943,484.536,486.681,488.163,491.946,494.105,497.218,501.002,502.484,506.267,508.34,511.753,514.867,517.019,520.203" y="685.9110000000001" svg_rhmargin="521.685" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Potential role of bcl-2 and ki-67 expression and apoptosis in colorectal</text>
  <text x="319.787,322.901,326.085,328.159,331.272,332.754,336.538,340.321,346.106,349.291,350.474,352.611,355.796,357.941,361.054,362.536,364.018,367.802,369.284,372.397,376.181,380.035,383.22,385.372,389.155,392.938,394.42,398.204,402.058,403.54,406.654,408.791,411.385,413.536,417.241,421.096,424.21,425.393,427.558,432.154,433.636,437.49100000000004,439.635,444.231,445.712,448.305,450.465,453.728,456.842,458.324,459.507,461.63,465.042,468.455,471.868,475.281,476.464,479.876,483.289,485.142,488.555,491.967,493.82,495.003,498.416,501.828,505.241" y="694.926" svg_rhmargin="508.654" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">carcinoma: a clinicopathologic study. Dig Dis Sci. 2003;48(10):1990</text>
  <text x="508.689" y="694.926" svg_rhmargin="512.251" style="fill:#131413;font-family:ILNNAP+PmmnvnAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="512.259,515.672" y="694.926" svg_rhmargin="516.855" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">7.</text>
  <text x="304.761,308.173,311.586,312.769,319.787,323.349,324.831,327.425,330.538,333.723,335.832,339.395,340.578,342.751,346.904,348.386,352.16900000000004,354.314,357.877,361.062,362.245,364.346,368.942,372.354,373.836,376.024,380.548,383.811,384.99399999999997,387.132,390.694,394.477,396.629,398.781,400.26300000000003,402.379,406.383,407.566,409.689,412.952,415.026,418.809,424.594,428.449,431.862,434.013,436.165,439.35,441.495,445.869,447.052,449.204,454.69,457.875,459.948,463.133,466.916,470.771,472.253,476.036,479.819,481.971,485.234,486.417,488.605,491.868,493.35,494.832,496.314,500.168,504.023,505.50500000000005,507.649,510.913,512.096,514.226,518.821" y="704.226" svg_rhmargin="520.303" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">20. Visca P, Alo PL, Del NF, Botti C, Trombetta G, Marandino F, Filippi S, Di</text>
  <text x="319.787,323.05,326.833,330.617,334.471,338.254,340.364,344.817,346.0,348.13,352.725,356.509,360.292,364.075,367.859,369.932,372.525,376.308,378.461,382.023,385.585,386.768,388.948,390.43,396.216,402.001,405.706,409.489,413.273,417.056,418.538,421.132,423.283,427.067,430.18,433.964,437.376,443.162,444.644,447.757,450.942,452.42400000000004,454.54,457.953,460.995,464.85,466.923,470.336,472.93,475.523,477.005,480.788,484.571,486.738,490.521,492.373,494.504,496.356,499.541,501.693,503.845,506.959,509.131,512.316,515.43,516.912" y="713.181" svg_rhmargin="520.767" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Tondo U, Donnorso RP. Immunohistochemical expression of fatty acid</text>
  <text x="319.787,322.38,325.494,329.277,331.429,335.212,338.397,340.991,344.404,345.587,347.738,350.923,354.777,358.561,362.415,364.567,368.35,370.502,371.984,375.098,377.171,379.244,382.657,386.512,390.217,391.699,394.884,397.035,398.517,402.301,406.156,408.342,412.197,415.61,419.393,422.806,425.4,426.58299999999997,428.691,432.546,434.619,438.403,439.884,441.366,443.219,446.632,448.705,451.89,454.042,455.524,459.307,463.16200000000003,465.313,467.166,470.351,473.464,475.616,479.399,481.473,484.066,485.24899999999997,487.422,490.607,494.39,498.245,500.404,502.477,505.662,508.255,510.378,514.233,516.306,520.09,522.241,525.654,527.136" y="722.196" svg_rhmargin="530.919" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">synthase, apoptotic-regulating genes, proliferating factors, and ras protein</text>
  <text x="319.787,323.642,325.715,329.498,333.353,337.058,340.171,342.323,344.446,345.928,349.711,351.87,354.984,358.767,360.249,364.033,366.106,369.519,372.632,374.784,377.969,379.451,381.574,384.759,388.614,392.026,395.81,399.593,405.378,408.563,411.157,412.34,414.513,417.626,420.811,422.884,425.998,427.48,431.263,435.047,440.832,444.017,446.61,447.793,449.945,453.13,456.913,460.76800000000003,462.926,466.111,469.966,471.448,474.633,477.746,481.159,484.942,487.094,489.232,493.015,496.798,500.582,504.365,507.778,511.561,515.416,516.898,520.082,522.676,524.828,526.31" y="731.211" svg_rhmargin="529.424" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">product in colorectal adenomas, carcinomas, and adjacent nonneoplastic</text>
  <text x="319.787,325.572,329.277,332.391,336.174,338.768,341.953,343.13599999999997,345.244,349.248,350.73,352.212,355.995,358.169,362.173,365.358,369.141,372.255,375.668,377.741,379.878,383.441,386.854,389.447,390.63,392.803,396.216,399.629,403.042,406.454,407.637,411.05,412.902,416.315,419.728,421.581,422.763,426.176,429.589,433.002" y="740.226" svg_rhmargin="436.415" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">mucosa. Clin Cancer Res. 1999;5(12):4111</text>
  <text x="436.407" y="740.226" svg_rhmargin="439.969" style="fill:#131413;font-family:ILNNAP+PmmnvnAdvTTb5929f4c+20;font-size:7.5px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="439.977,443.39" y="740.226" svg_rhmargin="444.573" style="fill:#131413;font-family:ILNNAO+HnbrjvAdvTTb5929f4c;font-size:7.5px;font-style:NORMAL;font-weight:normal;">8.</text>
  <text svg_rhmargin="69.093" x="56.693,60.437,64.765,69.093" y="48.13900000000001" style="fill:#131413;font-family:ILNNAN+RwhcrnAdvTTe45e47d2;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Luo </text>
  <text svg_rhmargin="129.148" x="71.493,75.069,77.565,79.941,84.101,85.845,87.509,89.916,93.996,100.156,104.572,106.924,111.34,115.5,119.748,123.076,126.652,129.148" y="48.13900000000001" style="fill:#131413;font-family:ILNPBH+WyvcsnAdvTT7329fd89.I;font-size:8.0px;font-style:NORMAL;font-weight:normal;">et al. BMC Cancer </text>
  <text svg_rhmargin="193.267" y="48.13900000000001" x="146.74,149.012,153.116,157.22,161.324,165.428,167.7,169.396,173.499,177.603,179.259,183.363,187.467,191.571,193.267" style="fill:#131413;font-family:MyriadPro-Regular;font-size:8.0px;font-style:NORMAL;font-weight:normal;">(2019) 19:123 </text>
  <text x="491.983,496.231,500.063,504.479,508.479,510.863,514.943,519.023,521.407,525.735,528.063,530.423,534.503" y="48.13900000000001" svg_rhmargin="538.583" style="fill:#131413;font-family:ILNNAN+RwhcrnAdvTTe45e47d2;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Page 12 of 13</text>
 </g>
</svg>
